Recently however, Scott et al. () showed that, while CBD treatment of glioma cells did induce a significant increase in ROS production, this. Targeting Glioma Initiating Cells with A combined therapy of and other cannabinoids including cannabidiol (CBD) exert antitumoral actions in. THC in C6 glioma was reported (Sánchez et al., ), and shrinkage of in situ human glioma cell line tumors was observed with CBD (Massi.
and glioma CBD
Cannabinoids Reduce Nausea and Vomiting. Cannabinoids Improve Other Cancer-related Symptoms. Anticancer Effects of Cannabinoids may be able to Prolong Life. The use of cannabis in supportive care and treatment of brain tumor Rudolf Likar. Abstract Cannabinoids are multitarget substances. For permissions, please e-mail: Email alerts New issue alert.
Receive exclusive offers and updates from Oxford Academic. More on this topic I-CoPE: A pilot study of structured supportive care delivery to people with newly diagnosed high-grade glioma and their carers. Analytical quality by design: Development and control strategy for a LC method to evaluate the cannabinoids content in cannabis olive oil extracts. Indazolylketones as new multitarget cannabinoid drugs.
Signal transduction pathways and resistance to targeted therapies in glioma. I would like to describe the different categories of marijuana derivatives and discuss some of the evidence that might indicate that they could be beneficial for patients. First off, marijuana is called cannabis, and molecules derived from cannabis are called cannabinoids. These are a diverse group of compounds that can act on receptors in the body called cannabinoid receptors.
Cannabinoids can be produced not only by marijuana but also endogenously in the human body and animals, or they can be produced synthetically. The most notable cannabinoid is THC, which is the primary psychoactive compound and marijuana.
Another type of constituent of the plant marijuana is called Cannabidiol CBD. There are dozens of different CBD molecules that can be isolated from marijuana and they all have different effects. CBD and its molecular derivatives have been shown to have potential against cancer.
Numerous reports have shown that CBD molecules can inhibit glioma cells both in vitro an in vivo by inducing a apoptosis, or programmed cell death, and they may also affect angiogenesis. Sean McAllister, have determined some of the molecular mechanisms by which CBD can inhibit glioblastoma cell growth. The researchers hope to start human trials soon. It appears that one general theme related to CBD molecules is that they increase the production of reactive oxygen species in tumor cells.
Reactive oxygen species are molecules like superoxide that can cause destruction of other molecules in the cellular environment and promote injury to cellular DNA. Thus, if CBD molecules induce DNA injury in a cell, and that cell is also being injured by another chemotherapeutic drug such as temozolomide, this combined injury may promote a generalized increase in sensitivity of the tumor cell to the chemotherapeutic drug.
In other words, CBD may increase the sensitivity of tumor cells to standard chemotherapeutic agents. It should be noted, there is no clear evidence that the other marijuana derivative THC has been found to be beneficial for patients in terms of blocking tumor growth. It is likely that smoking marijuana or consuming marijuana products will have little if any effect on glioblastoma growth, since it is unknown in any given source of marijuana whether or not the appropriate CBD may even be contained within the specimen being smoked or consumed.
In order to capitalize on the effects of CBD in glioblastoma and other malignancies, there are efforts underway by some biotech companies such as Stella therapeutics in Seattle, and GW Pharmaceuticals in the UK, to develop drugs to treat patients that target these pathways.
At this point, there is only one clinical trial ongoing which is being performed by GW pharmaceuticals in 15 countries.
Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
Glioblastoma is the primary brain tumour with the worst prognosis: of the THC+ CBD combination at a ratio, adding temozolomide and. THC:CBD was generally well tolerated with treatment emergent adverse events In glioma, THC and CBD appear to act via distinct signalling pathways. Furthermore, CBD inhibits tumor angiogenesis and infiltration/ invasion even at low concentrations and abrogates resistance of glioma stem-like cells to BCNU.